Global Nanopore Sequencing Market OverviewThe nanopore sequencing market is projected to grow at a CAGR of around 11% during the forecast period, driven by rising demand for real-time, portable DNA ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...

As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...

Antibody Specificity Testing Market is expected to Reach to US $1.9 Bn by 2035, Driven by Rising Demand for Personalized ...

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...

In a new paper presented at IEDM 2025, imec reports on the successful fabrication of highly uniform nanopores with diameters ...

Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key presentations at the conference highlighted ...

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.

The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.

PPGLs show marked skeletal tropism, with 75.7% of patients developing bone metastases, primarily in the spine, after surgical resection.